Bacterial and Viral Identification Rate in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea

Juwhan Choi1, Jee Youn Oh1, Young Seok Lee1

  • 1Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.

Yonsei Medical Journal
|January 23, 2019
PubMed
Abstract

Insights

Respiratory infections are key in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This study in Korea found varied bacterial and viral identification rates, with no pathogen identified in over a third of cases.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Epidemiology

Background:

  • Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is frequently triggered by respiratory infections.
  • Previous etiological studies on AECOPD have predominantly focused on Western populations.
  • Understanding the specific microbial landscape in different regions is crucial for effective AECOPD management.

Purpose of the Study:

  • To investigate the rates of bacterial and viral pathogen identification in patients with AECOPD in Korea.
  • To analyze the epidemiological characteristics of identified infections in relation to disease severity and outcomes.

Main Methods:

  • A retrospective analysis of 736 AECOPD cases was conducted at a Korean hospital.
  • Bacterial and viral identification rates were determined.
  • Infections were classified based on Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage, mortality, and seasonality.

Main Results:

  • No pathogen was identified in 36.7% of AECOPD cases. Bacterial, viral, and co-infections were identified in 27.2%, 21.6%, and 14.5% of cases, respectively.
  • Key identified bacteria included *Pseudomonas aeruginosa*, *Streptococcus pneumoniae*, and *Haemophilus influenzae*. Common viruses were influenza virus, rhinovirus, parainfluenza virus, and metapneumovirus.
  • Higher bacterial identification rates correlated with advanced COPD stages and mortality. Viral pathogens exhibited distinct seasonal patterns.

Conclusions:

  • This study provides essential epidemiological data on respiratory infections in Korean AECOPD patients.
  • Findings can inform targeted antibiotic and treatment strategies for AECOPD in this population.
  • Further research into unidentified pathogens is warranted.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K